Form 4: Quoin Pharmaceuticals Director Receives Stock Grant
Insider Transaction (Form 4)
Anthony James Culverwell, a Director of Quoin Pharmaceuticals, Ltd., received 31,352 shares of common stock on August 27, 2026.
Summary
- Grant/award: acquired 31,352 ADSs at $5.15 ($161,463) on August 27, 2026; holds 34,218 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Anthony James Culverwell — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-27 | Grant/award | ADSs | 31,352 | $5 | $161.5K | 34,218 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-27 | Grant/award (31,352 shares) |
Keywords
insider transaction, Form 4, QNRX, Quoin Pharmaceuticals, Ltd., neutral, Anthony James Culverwell
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.